HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (Hydrocodone Bitartrate and Homatropine Methylbromide) Nursing Considerations

What is the generic name?

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

What is the Trade Name for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?

Hydrocodone Bitartrate and Homatropine Methylbromide

What are the Indications for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?

• 1 INDICATIONS AND USAGE Hydrocodone bitartrate and homatropine methylbromide is indicated for the symptomatic relief of cough in patients 18 years of age and older. Important Limitations of Use : Not indicated for pediatric patients under 18 years of age [ see Use in Specific Populations (8.4) ]. Contraindicated in pediatric patients less than 6 years of age [ see Contraindications (4) ]. Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [ see Warnings and Precautions (5.1) ], reserve hydrocodone bitartrate and homatropine methylbromide for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made. Hydrocodone bitartrate and homatropine methylbromide is a combination of hydrocodone, an opioid agonist; and homatropine, a muscarinic antagonist, indicated for the symptomatic relief of cough in patients 18 years of age and older. (1) Important Limitations of Use (1) Not indicated for pediatric patients under 18 years of age. Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, reserve hydrocodone bitartrate and homatropine methylbromide for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made.

References: https://open.fda.gov/